361 related articles for article (PubMed ID: 22102982)
1. Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.
Grabrucker AM; Rowan M; Garner CC
Drug Deliv Lett; 2011 Sep; 1(1):13-23. PubMed ID: 22102982
[TBL] [Abstract][Full Text] [Related]
2. Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo.
Chhabra R; Ruozi B; Vilella A; Belletti D; Mangus K; Pfaender S; Sarowar T; Boeckers TM; Zoli M; Forni F; Vandelli MA; Tosi G; Grabrucker AM
CNS Neurol Disord Drug Targets; 2015; 14(8):1041-53. PubMed ID: 26295815
[TBL] [Abstract][Full Text] [Related]
3. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
4. Zinc and Central Nervous System Disorders.
Wang B; Fang T; Chen H
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432243
[TBL] [Abstract][Full Text] [Related]
5. Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer's disease.
Isaev NK; Stelmashook EV; Genrikhs EE
Rev Neurosci; 2020 Apr; 31(3):233-243. PubMed ID: 31747384
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
7. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal Imaging of Zinc Ions in Zebrafish Live Brain Tissue Enabled by Fluorescent Bionanoprobes.
Jarosova R; Woolfolk SK; Martinez-Rivera N; Jaeschke MW; Rosa-Molinar E; Tamerler C; Johnson MA
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903504
[TBL] [Abstract][Full Text] [Related]
9. Zinc: indications in brain disorders.
Prakash A; Bharti K; Majeed AB
Fundam Clin Pharmacol; 2015 Apr; 29(2):131-49. PubMed ID: 25659970
[TBL] [Abstract][Full Text] [Related]
10. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
[TBL] [Abstract][Full Text] [Related]
11. Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases.
Zhang YY; Li XS; Ren KD; Peng J; Luo XJ
Ageing Res Rev; 2023 Jun; 87():101931. PubMed ID: 37031723
[TBL] [Abstract][Full Text] [Related]
12. Zinc: From Biological Functions to Therapeutic Potential.
Costa MI; Sarmento-Ribeiro AB; Gonçalves AC
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902254
[TBL] [Abstract][Full Text] [Related]
13. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
14. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of brain metallothionein.
Ebadi M; Iversen PL; Hao R; Cerutis DR; Rojas P; Happe HK; Murrin LC; Pfeiffer RF
Neurochem Int; 1995 Jul; 27(1):1-22. PubMed ID: 7655341
[TBL] [Abstract][Full Text] [Related]
16. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease?
Johnson S
Med Hypotheses; 2001 May; 56(5):641-5. PubMed ID: 11388783
[TBL] [Abstract][Full Text] [Related]
17. Zinc modulates aluminium-induced oxidative stress and cellular injury in rat brain.
Singla N; Dhawan DK
Metallomics; 2014 Oct; 6(10):1941-50. PubMed ID: 25141099
[TBL] [Abstract][Full Text] [Related]
18. Iron chelation in the treatment of neurodegenerative diseases.
Dusek P; Schneider SA; Aaseth J
J Trace Elem Med Biol; 2016 Dec; 38():81-92. PubMed ID: 27033472
[TBL] [Abstract][Full Text] [Related]
19. Brain, aging and neurodegeneration: role of zinc ion availability.
Mocchegiani E; Bertoni-Freddari C; Marcellini F; Malavolta M
Prog Neurobiol; 2005 Apr; 75(6):367-90. PubMed ID: 15927345
[TBL] [Abstract][Full Text] [Related]
20. Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
DuMont M; Agostinis A; Singh K; Swan E; Buttle Y; Tropea D
Neurobiol Dis; 2023 Aug; 184():106214. PubMed ID: 37385457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
